387 related articles for article (PubMed ID: 18439169)
1. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
2. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
Marinskis G; van Erven L;
Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
[TBL] [Abstract][Full Text] [Related]
3. Managing cardiac devices near the end of life: a survey of hospice and palliative care providers.
Morrison LJ; Calvin AO; Nora H; Porter Storey C
Am J Hosp Palliat Care; 2010 Dec; 27(8):545-51. PubMed ID: 20713422
[TBL] [Abstract][Full Text] [Related]
4. Survey of cardiac pacing and defibrillation in the United States in 1993.
Bernstein AD; Parsonnet V
Am J Cardiol; 1996 Jul; 78(2):187-96. PubMed ID: 8712141
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
6. Requests to forgo potentially life-prolonging treatment and to hasten death in terminally ill cancer patients: a prospective study.
Georges JJ; Onwuteaka-Philipsen BD; van der Heide A; van der Wal G; van der Maas PJ
J Pain Symptom Manage; 2006 Feb; 31(2):100-10. PubMed ID: 16488343
[TBL] [Abstract][Full Text] [Related]
7. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
8. Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey.
Marinskis G; Bongiorni MG; Dagres N; Dobreanu D; Lewalter T; Blomström-Lundqvist C;
Europace; 2012 Dec; 14(12):1807-9. PubMed ID: 23134623
[TBL] [Abstract][Full Text] [Related]
9. Physician management of pacemaker and implantable cardioverter defibrillator advisories.
Maisel WH
Pacing Clin Electrophysiol; 2004 Apr; 27(4):437-42. PubMed ID: 15078394
[TBL] [Abstract][Full Text] [Related]
10. Recovery of pacemakers and defibrillators for analysis and device advance directives: electrophysiologists' perspectives.
Logani S; Gottlieb M; Verdino RJ; Baman TS; Eagle KA; Kirkpatrick JN
Pacing Clin Electrophysiol; 2011 Jun; 34(6):659-65. PubMed ID: 21314698
[TBL] [Abstract][Full Text] [Related]
11. Survey of cardiac rhythm management and device implant patterns in Puerto Rico: analysis of 13,854 cardiac implants.
Aranda JM; Girod M; Ochoa F; Abreu M; Rivera JJ; Sotomonte JC; Rodríguez A; Arzola D; Fiménez R; Aranda JM
Bol Asoc Med P R; 2008; 100(1):39-49. PubMed ID: 18763396
[TBL] [Abstract][Full Text] [Related]
12. Postmortem interrogation and retrieval of implantable pacemakers and defibrillators: a survey of morticians and patients.
Kirkpatrick JN; Ghani SN; Burke MC; Knight BP
J Cardiovasc Electrophysiol; 2007 May; 18(5):478-82. PubMed ID: 17313530
[TBL] [Abstract][Full Text] [Related]
13. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
[No Abstract] [Full Text] [Related]
14. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
Lampert R
Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
[TBL] [Abstract][Full Text] [Related]
15. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
McGeary A; Eldergill A
Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
[TBL] [Abstract][Full Text] [Related]
16. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
Kay GN; Bittner GT
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
[No Abstract] [Full Text] [Related]
17. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
[TBL] [Abstract][Full Text] [Related]
18. [Deactivating pacemakers in terminally ill patients].
Hotvedt R
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
[No Abstract] [Full Text] [Related]
19. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
20. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
